by McKesson Ventures | Apr 1, 2019 | Portfolio News
Seattle-based digital prescribing platform Xealth today announced that it has raised $11 million in a Series A financing round. The funds will fuel the expansion of Xealth’s platform, allowing it to better connect patients and doctors. McKesson Ventures, Novartis,...
by McKesson Ventures | Mar 21, 2019 | Portfolio News
Aledade recently announced a series of promotions in its leadership team. Co-founder Edwin Miller has moved into the role of Chief Product Officer; the company named athenahealth veteran Brady Richards as its new Chief Technology Officer; and Emily Maxson, MD, was...
by McKesson Ventures | Mar 21, 2019 | Portfolio News
In a paper recently published in the New England Journal of Medicine, researchers from McLean Hospital and Harvard Medical School said that certain drugs prescribed to teens and young adults with ADHD increase the risk of psychosis. The study, funded by the National...
by McKesson Ventures | Mar 21, 2019 | Portfolio News
Health insurance company Humana is teaming up with health consumer experience firm Accolade to “better provide a differentiated healthcare and benefits experience for consumers,” the companies say. The companies intend to partner in order to offer a well-rounded...
by McKesson Ventures | Mar 15, 2019 | Portfolio News
Last week, Rock Health co-hosted an event with Kaiser Permanente Ventures (KPV) that brought together leaders from Kaiser Permanente and Validic to discuss how to build a successful enterprise-startup partnership. Validic is a KPV portfolio company and has been...
by McKesson Ventures | Mar 15, 2019 | Portfolio News
Physera, an app-based platform for musculoskeletal exercises and remote consultations with physical therapists, has raised $8 million in a Series A round led by BlueCross Blueshield Venture Partners. The company has now raised a total of $10 million. Other funders,...
